Skip to main content
SpringerLink
Log in

Type I glycogen storage disease: Kidney involvement, pathogenesis and its treatment

  • Invited Review
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Type I glycogen storage disease (GSD-I) is due to the deficiency of glucose-6-phosphatase activity in the liver, kidney and intestine. Although kidney enlargement occurs in GSD-I, renal disease has not been considered a major problem until recently. In older patients (more than 20 years of age) whose GSD-I disease has been ineffectively treated, virtually all have disturbed renal function, manifested by persistent proteinuria; many also have hypertension, renal stones, altered creatinine clearance or a progressive renal insufficiency. Glomerular hyperfiltration is seen in the early stage of the renal dysfunction and can occur before proteinuria. In younger GSD-I patients, the hyperfiltration is usually the only renal abnormality found; and, in some patients, microalbuminuria develops before clinical proteinuria. The predominant underlying renal pathology is focal segmental glomerulosclerosis. Renal stones and/or nephrocalcinosis are also common findings. Amyloidosis and Fanconi-like syndrome can occur, but rarely. The risk factors for developing the glomerulosclerosis in GSD-I include hyperfiltration, hypertension, hyperlipidemia and hyperuricemia. Dietary therapy with cornstarch and/or nasogastric infusion of glucose, aimed at maintaining normoglycemia, corrects metabolic abnormalities and improves the proximal renal tubular function. Long-term trial will be needed to assess whether the dietary therapy may prevent the evolution or the progression of the renal disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Chen Y-T (1989) Disorders of carbohydrate metabolism (excluding diabetes). In: Kelley WN (ed) Textbook of internal medicine. Lippincott, Pennsylvania, pp 2270–2273

    Google Scholar 

  2. Hers H-G, Hoof F van, Barsy T de (1989) Glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn, vol 1. McGraw-Hill, New York, pp 425–452

    Google Scholar 

  3. Cohen J, Friedman M (1979) Renal tubular acidosis associated with type III glycogenosis. Acta Paediatr Scand 68: 779–782

    Google Scholar 

  4. DiMauro S (1978) Metabolic myopathies. In: Vinken PJ, Bruyn GW, Ringel SP (eds) Handbook of clinical neurology. North Holland, Amsterdam, pp 175–234

    Google Scholar 

  5. Grunfeld JP, Ganeval D, Chanard J, Fardeau M, Dreyfus JC (1972) Acute renal failure in McArdle's disease. N Engl J Med 286: 1237

    Google Scholar 

  6. Bank WJ, Dimauro S, Rowland LP (1972) Renal failure in McArdle's disease. N Engl J Med 287: 1102

    Google Scholar 

  7. McDermott M, Piegari G, Hofeldt FD (1982) Acute renal failure in McArdle's disease. South Med J 75: 309–312

    Google Scholar 

  8. Fanconia VG, Bickel H (1949) Die chronische Aminoacidurie (Aminosäurediabetes oder nephrotisch-glukosurischer Zwergwuchs) bei der Glykogenose und der Cystinkrankheit. Helv Paediatr Acta 4: 359–396

    Google Scholar 

  9. Rotthauwe HW, Fichsel H, Heldt HW, Kirsten E, Reim M, Schmidt E, Schmidt FW, Wesemann W (1963) Glykogenose der Leber mit Aminoacidurie und Glucosurie: Klinische und biochemische Untersuchungen. Klin Wochenschr 41: 818–825

    Google Scholar 

  10. Odièvre M (1966) Glycogenose hépato-rénale avec tubulopathie congénitale: deux observations d'une entité nouvelle. Rev Int Hepatol 16: 1–70

    Google Scholar 

  11. Garty R, Cooper R, Tabachnik E (1974) The Fanconi syndrome associated with hepatic glycogenosis and abnormal metabolism of galactose. J Pediatr 85: 821–823

    Google Scholar 

  12. Brivet M, Moatti N, Corriat A, Lemonnier A, Odièvre M (1983) Defective galactose oxidation in a patient with glycogen storage disease and Fanconi syndrome. Pediatr Res 17: 157–161

    Google Scholar 

  13. Hurvitz H, Elpeleg ON, Barash V, Kerem E, Reifen RM, Ruitenbee K, Mor C, Branski D (1989) Glycogen storage disease, Fanconi nephropathy, abnormal galactose metabolism and mitochondrial myopathy. Eur J Pediatr 149: 48–51

    Google Scholar 

  14. Holling HE (1963) Gout and glycogen storage disease. Ann Intern Med 58: 654–663

    Google Scholar 

  15. Sonobe H, Ogawa K, Takahashi I (1976) Familial nephropathy associated with hepatic type of glycogen storage disease. Acta Pathol Jpn 26: 727–738

    Google Scholar 

  16. Steim H, Zollinger HU (1967) Tödliche Schrumpfniere bei Glykogenspeicherkrankheit Typ von Gierke. Klin Wochenschr 45: 295–299

    Google Scholar 

  17. Nishio S, Oka K, Tanaka K, Imagawa E, Omae T (1981) Type 1 glycogenosis with contracted kidneys and liver cell adenoma. Acta Pathol Jpn 31: 873–881

    Google Scholar 

  18. Chen YT, Coleman RA, Scheinman JI, Kolbeck PC, Sidbury JB (1988) Renal disease in type I glycogen storage disease. N Engl J Med 318: 7–11

    Google Scholar 

  19. Alaupovic P, Fernandes J (1985) The serum apolipoprotein profile of patients with glucose-6-phosphatase deficiency. Pediatr Res 19: 380–384

    Google Scholar 

  20. Levy E, Thiabault LA, Roy CC, Bendayan M, Lepage G, Letarte J (1988) Circulating lipids and lipoproteins in glycogen storage disease type I with nocturnal intragastric feeding. J Lipid Res 29: 215–226

    Google Scholar 

  21. Greene HL, Slonim AE, O'Neill JA Jr., Burr IM (1976) Continuous nocturnal intragastric feeding for management of type I glycogenstorage disease. N Engl J Med 294: 423–425

    Google Scholar 

  22. Chen Y-T, Cornblath M, Sidbury JB (1984) Cornstarch therapy in type I glycogen-storage disease. N Engl J Med 310: 171–175

    Google Scholar 

  23. Wolfsdorf JI, Keller RJ, Landy H, Crigler JF Jr (1989) Glucose therapy of infants with type I glycogenosis (GSD): comparison of intermittent uncooked cornstarch (UCS) and continuous overnight glucose (COG) feedings. Pediatr Res 25: 205A

    Google Scholar 

  24. Baker L, Dahlem S, Goldfarb S, Kern EFO, Stanley CA, Egler J, Olshan JS, Heyman S (1989) Hyperfiltration and renal disease in glycogen storage disease, type I. Kidney Int 35: 1345–1350

    Google Scholar 

  25. Chen Y-T, Coleman RA, Scheinman JI (1988) Glomerular and tubular dysfunction in type I glycogen storage disease (GSD-I): improvement with cornstarch therapy. Am J Hum Genet 43: A3

    Google Scholar 

  26. Gehiig JJ, Wolfe JA (1988) Renal disease in type I glycogen storage disease. N Engl J Med 318: 1759–1760

    Google Scholar 

  27. Parscau L de, Guibaud P, Labrune P, Odièvre M (1990) Long term outcome of hepatic glycogen storage diseases: the French experience. J Inherited Metab Dis (in press)

  28. Emmett M, Narins RG (1978) Renal transplantation in type I glycogenosis: failure to improve glucose metabolism. JAMA 239: 1642–1644

    Google Scholar 

  29. Jonas AJ, Verani RR, Howell RR, Conley SB (1988) Hypertension in a child with type Ia glycogen storage disease. Am J Kidney Dis II: 264–266

    Google Scholar 

  30. Verani R, Bernstein J (1988) Renal glomerular and tubular abnormalities in glycogen storage disease type I. Arch Pathol Lab Med 112: 271–274

    Google Scholar 

  31. Poe R, Snover DC (1988) Adenomas in glycogen storage disease type I: two cases with unusual histologic features. Am J Surg Pathol 12: 477–483

    Google Scholar 

  32. Kikuchi M, Haginoya K, Miyabayashi S, Igarashi Y, Narisawa K, Tada K (1990) Secondary amyloidosis in glycogen storage disease type Ib. Eur J Pediatr 149: 344–345

    Google Scholar 

  33. Matsuo N, Tsuchiya Y, Cho H, Nagai T, Tsuji A (1986) Proximal renal tubular acidosis in a child with type I glycogen storage disease. Acta Paediatr Scand 75: 332–335

    Google Scholar 

  34. Lampert F, Mayer H, Tocci PM, Nyhan WL (1967) Fanconi syndrome in glycogen storage disease. In: Nyhan WL (ed) Amino acid metabolism and genetic variation. McGraw-Hill, New York, pp 353–362

    Google Scholar 

  35. Chen YT, Scheinman JI, Park HK, Coleman RA, Roe CR (1990) Amelioration of proximal renal tubular dysfunction in type I glycogen storage disease with dietary therapy. N Engl J Med 323: 590–593

    Google Scholar 

  36. Restaino I, Stanley C, Baker L, Weiss R, Kaplan BS (1990) Renal tubular abnormalities and nephrocalcinosis in patients with type Ia glycogen storage disease. Pediatr Res 27: 337A

    Google Scholar 

  37. Ditzel J, Schwartz M (1967) Abnormally increased glomerular filtration rate in short-term insulin-treated diabetic subjects. Diabetes 16: 264–267

    Google Scholar 

  38. Mogensen CE (1976) Renal function changes in diabetes. Diabetes 25: 872–879

    Google Scholar 

  39. Goldszer RC, Sweet J, Cotran RS (1984) Focal segmental glomerulosclerosis. Annu Rev Med 35: 429–449

    Google Scholar 

  40. Brenner BM, Meyer TW, Hostetter TH (1982) Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307: 652–659

    Google Scholar 

  41. Hostetter TH, Rennke HG, Brenner BM (1982) The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72: 375–380

    Google Scholar 

  42. Chen YT, Feinstein KA, Coleman RA, Effman EL (1990) Variability of renal length in type I glycogen storage disease. J Inherited Metab Dis 13: 259–262

    Google Scholar 

  43. Beck LH (1986) Requiem for gouty nephropathy. Kidney Int 30: 280–287

    Google Scholar 

  44. Keane WF, Kasiske BL, O'Donnell MP (1988) Hyperlipidemia and the progression of renal disease. Am J Clin Nutr 47: 157–160

    Google Scholar 

  45. Peric-Golia L, Peric-Golia M (1983) Aortic and renal lesions in hypercholesterolemic adult male virgin Sprague-Dawley rats. Atherosclerosis 46: 57–65

    Google Scholar 

  46. French SW, Yamanaka W, Ostwald R (1967) Dietary induced glomerulosclerosis in the guinea pig. Arch Pathol 83: 204–210

    Google Scholar 

  47. Wellmann K, Volk BW (1970) Renal changes in experimental hypercholesterolemia in normal and in subdiabetic rabbits. Lab Invest 22: 144–155

    Google Scholar 

  48. Kasiske BL, O'Donnell MP, Cleary MP, Keane WF (1988) Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 33: 667–672

    Google Scholar 

  49. Moorhead JF, Chan MK, El-Nahas M, Varghese A (1982) Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet II: 1309–1311

    Google Scholar 

  50. Keen H, Chlouverakis C, Fuller J, Jarrett RJ (1969) The concomitants of raised blood sugar: studies in newly-detected hyperglycaemics. Guy's Hosp Reports 118: 247–254

    Google Scholar 

  51. Fernandez J, Jansen H, Jansen TC (1979) Nocturnal gastric drip feeding in glucose-6-phosphatase deficient children. Pediatr Res 13: 225–229

    Google Scholar 

  52. Nikkila EA, Huttunen JK, Ehnholm C (1977) Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Diabetes 26: 11–15

    Google Scholar 

  53. Chen YT, Scheinman JI (1990) Hyperglycemia associated with lactic acidemia in a renal allograft recipient with type I glycogen storage disease. J Inherited Metab Dis (in press)

  54. Addis T (1948) Glomerular nephritis: diagnosis and treatment. Macmillan, New York

    Google Scholar 

  55. Ihle BU, Becker GJ, Whitworth JA, Charlwood RA, Kincaid-Smith PS (1989) The effect of protein restriction on the progression of renal insufficiency. N Engl J Med 231: 1773–1777

    Google Scholar 

  56. Baker L, Kern EFO, Olshan J, Goldfarb S, Dahlem ST (1988) Pilot study of captopril in patients with renal disease associated with glycogen storage disease, type I (GSD-I). Pediatr Res 23: 388A

    Google Scholar 

  57. Taguma Y, Kitamoto Y, Futaki G, Veda H, Monma H, Ishizaki M, Takahashi H, Sekino H, Sasaki Y (1985) Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med 313: 1617–1620

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Division of Genetics and Metabolism, Duke University Medical Center, 27710, Durham, North Carolina, USA

    Yuan-Tsong Chen

Authors
  1. Yuan-Tsong Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, YT. Type I glycogen storage disease: Kidney involvement, pathogenesis and its treatment. Pediatr Nephrol 5, 71–76 (1991). https://doi.org/10.1007/BF00852851

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00852851

Key words

Search

Navigation